Given Imaging rival wins FDA approval
Olympus's capsule is used for small bowel imaging.
Market sources believe that Given Imaging will be affected in the short-term, because of Olympus's strong marketing operations, but this will be offset over time since Olympus's entry is likely to expand the market as a whole.
Given Imaging fell 4.85% in afternoon trading on the TASE. The company currently has a market cap of $723 million.
Published by Globes [online], Israel business news - www.globes.co.il - on September 18, 2007
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options